RxDoctor Payments DataLook up a doctor →

Jennifer Strong, APRN

Gerontology · Trinity, FLNPI 1982144291

Payments from drug & device makers

$6,762in general payments, 2019–2025

Across 337 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$730
  • Johnson & Johnson$593
  • AstraZeneca$476
  • Daiichi Sankyo Inc.$402
  • Seagen Inc.$359
  • Bayer$306
  • plus $4K from 46 others

What the payments were for

  • Food & beverage$6,38094%
  • Education$3816%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,762 in reported general payments places this provider in the 90th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$6,131
Medicare patients
62
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase11$25,764
Ondansetron Hcl15$1,290
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg12$318
Neomycin Sulfate15$60
Metronidazole15$15

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$233$25,76411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 714 gerontology providers in Florida.

Other gerontology in Trinity

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →